Skip to main content
. 2020 Mar 27;11:361. doi: 10.3389/fphar.2020.00361

Figure 1.

Figure 1

The effect of rifampicin (600 mg per day for one week) vs. placebo on the expression of lipid transporters and receptors involved in their regulation in the mononuclear cells of healthy volunteers in vivo (n = 12) as measured with quantitative RT-PCR. The data are presented as the mean intraindividual ratio (rifampicin to placebo) of transcript expression levels +SD. *P < 0.05; one-sample t-test.